CDERLearn Training and Education
Learning opportunities for healthcare professionals, academia, students, and consumers
Search General Courses Search Industry Courses
Upcoming Free CE Opportunities
Summary | Type | Topic |
---|---|---|
FDA 101: An Overview of FDA's Regulatory Review and Research Activities | Case Study; Health Care Professionals; Patients; Videos; Webinars | COVID-19; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Electronic Submissions; Generic Drugs; IND; MedWatch; Opioids; Women's Health |
FDA approval of Epkinly (epcoritamab-bysp) | Health Care Professionals; Patients; Podcasts | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
FDA approval of Polivy (polatuzumab vedotin-piiq) | Health Care Professionals; Patients; Podcasts | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions | Health Care Professionals; Patients; Podcasts | Drug Regulatory Process; Drug Safety; MedWatch |
FDA approval of Omisirge (omidubicel-onlv) | Health Care Professionals; Patients; Podcasts | Cancer Drugs, Disease States, Drug Development, Drug Regulatory Process, Drug Safety |
FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use | Health Care Professionals; Patients; Podcasts | Drug Development; Drug Regulatory Process; Drug Safety; MedWatch; Opioids |
FDA approval of Padcev (enfortumab vedotin-ejfv) with Keytruda (pembrolizumab) | Health Care Professionals; Patients; Podcasts | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
FDA approval of Zynyz (retifanlimab-dlwr) | Health Care Professionals; Patients; Podcasts | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Compounding Quality Center of Excellence Annual Conference | Health Care Professionals, Patients, Podcasts, Social Media, Webinars | Compounding, COVID-19, Drug Development, Drug Regulatory Process, Drug Safety |
Conversations on Cancer: “Cancer Misinformation: Truth or Consequences” | Case Study, Health Care Professionals, Patients, Podcasts, Social Media, Webinars | Cancer Drugs, Disease States, Drug Development, Drug Regulatory Process, Drug Safety |
Stability and Beyond Use Dates | CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch |
FDA approval of Tafinlar (dabrafenib) with Mekinist (trametinib) for pediatric patients with low-grade glioma with a BRAF V600E mutation | Health Care Professionals; Patients; Podcasts | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
FDA approval of Verzenio (abemaciclib) | Health Care Professionals; Patients; Podcasts; Women’s Health | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
FDA approval of Jemperli (dostarlimab-gxly) | Health Care Professionals; Patients; Podcasts; Women’s Health | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
FDA approval of Trodelvy (sacituzumab govitecan-hziy) | Health Care Professionals; Patients; Podcasts; Women’s Health | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
FDA approvals of Jaypirca (pirtobrutinib) and Orserdu (elacestrant) | Health Care Professionals; Patients; Podcasts; Women’s Health | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
FDA approval of Keytruda (pembrolizumab) | Health Care Professionals; Patients; Podcasts | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
FDA approvals of Tukysa (tucatinib) | Health Care Professionals; Patients; Podcasts | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Biosimilars: What Patients Need to Know | Patients; Graphics | Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
Biosimilars: What Patients With Diabetes Need To Know | Patients; Graphics | Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
Biosimilar Basics | Patients; Graphics | Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
Biosimilares: Lo que los pacientes deben saber | Patients; Graphics | Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
Biosimilares: Lo que los pacientes con diabetes deben saber | Patients; Graphics | Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
Conceptos básicos sobre los biosimilares | Patients; Graphics | Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
Biosimilar Basics for Patients | Patients; Graphics | Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
Airflow | CE Credits; Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Personnel Gowning in Sterile Drug Production | Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Insanitary Conditions and Sterility Assurance | Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Supplier/Contractor Qualification and Management | Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Investigations and Corrective and Preventive Actions (CAPA) | Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Outsourcing Facility Guide | Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Sterility Testing: Common Misconceptions | CE Credits; Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Regulatory Framework for Human Drug Compounding | CE Credits; Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Aseptic Process Simulations (Media Fills) | Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
MedWatch, Your Report Can Make a Difference with Dr. Gerald Dal Pan | Health Care Professionals; Podcasts | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch |
Expanded Access with Dr. Jacqueline Corrigan-Curay | Health Care Professionals; Patients; Graphics | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; IND |
Are you on a biologic medication? | Patients; Graphics | Biosimilars; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Summary Report for Biosimilars | Health Care Professionals; Patients; Graphics | Biosimilars; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Biosimilars Multimedia Education Materials | Health Care Professionals; Patients; Graphics; Podcasts; Social Media; Videos; Webinars | Biosimilars; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Biosimilars Overview for Health Care Professionals | Health Care Professionals; Graphics; Podcasts; Videos; Webinars | Biosimilars; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
FDA 101: An Overview of FDA's Regulatory Review and Research Activities | Health Care Professionals; Patients; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND; OTC Drug Regulations; Women’s Health |
FDA Insight | Health Care Professionals; Patients; Podcasts | Compounding; COVID-19; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Opioids; Women’s Health; OTC Drug Regulations |
Health Equity Forum Podcast | Health Care Professionals; Patients; Podcasts | COVID-19; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Diabetes; Women’s Health |
MedWatch, Your Report Can Make a Difference | Health Care Professionals; Patients; Podcasts | Drug Safety; MedWatch; Generic Drugs; Disease States; Drug Regulatory Process |
Pregnancy and Lactation Medication Information for the Healthcare Provider | CE Credits; Health Care Professionals; Webinars; Videos; Social Media | Women’s Health; Disease States; Drug Regulatory Process; Drug Safety |
Minority Health and Health Equity Webinars | Health Care Professionals; Patients; Podcasts; Videos; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Why Does the FDA Exist? | Health Care Professionals; Patients; Videos; Podcasts; Social Media | Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Achieving Data Quality and Integrity in Maximum Containment Laboratories | Health Care Professionals; Patients; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; |
Topics in Public Health | CE Credits; Health Care Professionals; Patients; Case Study; Webinars | Biomarker; Biosimilars; Cancer Drugs; Compounding; COVID-19; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND; MedWatch; Opioids; OTC Drug Regulations; Women's Health |
Conversations on Cancer: "What's on the Horizon: Future of Cancer Care" | Health Care Professionals; Patients; Webinars | Cancer Drugs; Disease States |
Conversations on Cancer: “Seasons of Change: Oncology Careers” | Health Care Professionals; Patients; Webinars | Cancer Drugs; Disease States |
Application of Artificial Intelligence and Machine Learning for Precision Medicine | Health Care Professionals; Patients; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Joint US FDA – Health Canada ICH Public Meeting | Health Care Professionals; Patients; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; IND |
FDA Rare Disease Day 2023 | Health Care Professionals; Patients; Webinars | Biomarker; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Risk Evaluation and Mitigation Strategies (REMS) Program Part 1 | Health Care Professionals; Patients; Graphics | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
Risk Evaluation and Mitigation Strategies (REMS) Program Part 2 | Health Care Professionals; Patients; Graphics | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
International 2022 Drug-Induced Kidney Injury Biomarker Workshop Day 1 and Day 2 | Health Care Professionals; Patients; Videos | Biomarker; Disease States; Drug Development; Drug Regulatory Process |
Advancing Regulatory Science at FDA | Health Care Professionals; Patients; Graphics | Biomarker; Disease States; Drug Development; Drug Regulatory Process |
Accelerating Access to Critical Therapies for ALS | Health Care Professionals; Patients; Graphics; Videos | Biomarker; Disease States; Drug Development; Drug Regulatory Process |
Accelerating Rare disease Cures (ARC) Program | Health Care Professionals; Patients; Videos | Biomarker; Disease States; Drug Development; Drug Regulatory Process |
Successes and Opportunities in Modeling and Simulation for FDA | Health Care Professionals; Patients; Graphics | Biomarker; Disease States; Drug Development; Drug Regulatory Process |
FDA's Work to Combat the COVID-19 Pandemic | Health Care Professionals; Patients; Graphics | COVID-19; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Working with patient advocacy groups | Health Care Professionals; Patients; Podcasts | Biomarker; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Drug compounding | Health Care Professionals; Patients; Podcasts | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Talking translational science | Health Care Professionals; Patients; Podcasts | Biomarker; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Addressing the Opioid Epidemic | Health Care Professionals; Patients; Podcasts | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Opioids |
Antibiotic Misuse and Resistance | Health Care Professionals; Patients; Podcasts | Disease States; Drug Safety; MedWatch |
FDA's Adverse Event Reporting System (FAERS) | Health Care Professionals; Patients; Podcasts | Drug Safety; MedWatch; Generic Drugs |
Breakthrough Therapy Designation | Health Care Professionals; Patients; Podcasts | Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Biosimilars: Are they the same quality? | Health Care Professionals; Patients; Graphics | Biosimilars; Disease States; Drug Regulatory Process; Drug Development; Drug Safety |
How to Use the Consumer Complaint System and MedWatch | Health Care Professionals; Patients | Drug Safety; MedWatch |
Reporting Unlawful Sales of Medical Products on the Internet | Health Care Professionals; Patients | Drug Safety |
Health Fraud Product Database | Health Care Professionals; Patients | Drug Safety |
Compounding Outsourcing Facilities Annual Study | Health Care Professionals; Patients; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Compounding Quality Center of Excellence Virtual Conference | Health Care Professionals; Patients; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
State of Outsourcing Facility Sector and Possibilities for the Future | Health Care Professionals; Patients; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Areas of Customer Need for Outsourcing Facility Products | Health Care Professionals; Patients; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Compounding Quality Center of Excellence Cross-Sector | Health Care Professionals; Patients; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Compounding Quality Center of Excellence Virtual Live Training | CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch |
Equity of Voices video series | Health Care Professionals; Patients; Case Study; Podcasts; Videos; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch |
Biosimilars in the Real World: Perspectives for Staying Within the Scope of Care | CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch |
Pregnancy and Lactation Medication Information for the Healthcare Provider: | Health Care Professionals; Patients; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Women's Health |
Leveraging Real-World Data to Study Medication Use in Pregnancy and Lactation | Health Care Professionals; Patients; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Women's Health |
CBD and Other Cannabinoids: Sex and Gender Differences in Use and Responses | Health Care Professionals; Patients; Webinars | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Opioids; Women's Health |
Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender | Health Care Professionals; Patients; Webinars | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Opioids; Women's Health |
Maximizing Benefits and Minimizing Harms from Antibiotics | Health Care Professionals; Patients; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch |
Health Fraud Scams | Health Care Professionals; Patients; Webinars | Drug Safety |
6 Tip-Offs to Rip-Offs: Don't Fall for Health Fraud Scams | Health Care Professionals; Patients; Webinars | Drug Safety |
BeSafeRx: Your Source for Online Pharmacy Information | Health Care Professionals; Patients; Webinars | Drug Safety |
Health Care Professionals; Patients; Podcasts; Videos | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch | |
FDA's Overdose Prevention Framework with Dr. Marta Sokolowska | Health Care Professionals; Patients; Podcasts | Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Opioids; Cancer Drugs |
FDA Health Playbook | Health Care Professionals; Patients; Videos; Graphics; Podcasts; Social Media | Drug Safety; OTC Drug Regulations; MedWatch; Opioids |
14th Annual Sentinel Initiative Public Workshop | Health Care Professionals; Patients; Webinars | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety |
Medical Extended Reality: Applications and Challenges | Health Care Professionals; Patients; Webinars | Disease States; Drug Regulatory Process; Drug Development; Drug Safety |
Highlights in Oncofertility: Trends in an Emerging Field for Cancer Survivors |
Health Care Professionals; Patients; Webinars | Cancer Drugs; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Women’s Health |
What does FDA regulate? | Health Care Professionals; Patients; Videos; Graphics | Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; OTC Drug Regulations; Women’s Health |
FDA Grand Rounds | Health Care Professionals; Patients; Webinars | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; OTC Drug Regulations; Biosimilars; IND; Cancer Drugs; Biomarker; Women’s Health |
Safe Opioid Disposal | Safe Opioid Disposal - Remove the Risk Outreach Toolkit | Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; Cancer Drugs; Opioids |
What Does FDA Do? | Health Care Professionals; Patients; Videos | Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; OTC Drug Regulations; IND; Women’s Health |
Conversation on Paxlovid with Dr. John Farley | Health Care Professionals; Patients; Podcasts | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety |
Clinical Trial Basics with Dr. Robert Temple | Health Care Professionals; Patients; Podcasts | Disease States; Drug Regulatory Process; Drug Development; Drug Safety; IND; Biomarker; Women’s Health |
Biosimilars Patient Materials | Graphics; Videos; Patients | Biosimilars; Drug Regulatory Process; Drug Development; Disease States; Drug Safety |
Clinical Trial Basics | Health Care Professionals; Podcasts | Biomarkers; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; IND; Women’s Health |
Adverse Events Associated with Compounded Drugs from Outsourcing Facilities | Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch |
Biosimilars 101: A Primer for Your Practice | CE Credits; Health Care Professionals; Case Study | Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
Incorporating Biosimilars Into the Management of Patients With Immunological Conditions | CE Credits; Health Care Professionals; Case Study | Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
Putting the Patient into Perspective: Strategies for Educating Patients about Biosimilars | CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
Biosimilars Resources | Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Biosimilars; Drug Regulatory Process; Drug Development |
Bridging Efficacy and Safety to the Obese | Health Care Professionals; Webinars | Biomarker; Cancer Drugs; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND; MedWatch; Women's Health |
Engaging Providers to Address Knowledge Gaps on Medication Use in Pregnancy and Lactation | CE Credits; Health Care Professionals; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Women's Health |
Biosimilars Videos | Healthcare Professionals; Videos Biosimilars; Drug Regulatory Process | Drug Development |
Biosimilars Level 2: Regulatory and Scientific Concepts | Case Study | Health Care Professionals |
Biosimilars Level 1: Foundational Concepts | Case Study | Health Care Professionals |
Increasing the Efficiency of Biosimilar Development Programs | Health Care Professionals; Webinars | Biosimilars; Drug Regulatory Process; Drug Development |
Successfully Navigating the USPTO and FDA | CE Credits; Webinars | Drug Development; Drug Regulatory Process; Drug Safety; Registration and Listing |
The History of FDA | Health Care Professionals; Webinars | Drug Development; Drug Regulatory Process; Drug Safety |
Bench to Bedside: Integrating Sex and Gender to Improve Human Health | CE Credits; Health Care Professionals; Webinars | Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Women's Health |
Q&A with FDA | Health Care Professionals; Podcasts | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch |
Biosimilars Level 1: Foundational Concepts | Health Care Professionals; Case Study | Biosimilars; Drug Regulatory Process; Drug Development |
Biosimilars Level 2: Regulatory and Scientific Concepts | Health Care Professionals; Case Study | Biosimilars; Drug Regulatory Process; Drug Development |
Biosimilars Curriculum Materials | Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Biosimilars; Drug Regulatory Process; Drug Development |
Drug Approval Case Studies | Case Study; Health Care Professionals; Patients; Graphics | Diabetes; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND |
FDA's Role in Public Health: Drug Efficacy, Safety, Quality, and Beyond | Health Care Professionals; CE Credits | Drug Regulatory Process |
Practitioners' Guide for Improving Oral Anticoagulant Use | Health Care Professionals; CE Credits | Oral Anticoagulant; Disease States |
The FDA Bad Ad Program and Prescription Drug Promotion | Health Care Professionals | Prescription Drug Promotion |
FDA MedWatch and Patient Safety | Health Care Professionals | MedWatch; Drug Safety |
The FDA Process for Approving Generic Drugs | Health Care Professionals | Drug Regulatory Process; Drug Development; Generic Drugs |
FDA Overview of Biosimilar Products | Health Care Professionals; Videos | Biosimilars; Drug Regulatory Process; Drug Development |
Leveraging Health Literacy and Patient Preferences to Reduce Hypoglycemia Events in Patients with Type 2 Diabetes | Health Care Professionals | Diabetes; Disease States |
Director's Corner Podcasts | Health Care Professionals; Podcasts | Drug Regulatory Process; Drug Development; Compounding; Generic Drugs; Drug Safety; MedWatch; Disease States |
Drug Information Soundcast in Clinical Oncology (D.I.S.C.O) | Health Care Professionals; Podcasts | Cancer Drugs; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
FDA Drug Safety Podcasts | Health Care Professionals; Podcasts | Drug Safety; Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
Regulatory Science at CDER Podcasts | Health Care Professionals; Podcasts | Drug Development; Disease States; Drug Regulatory Process; Drug Safety; IND |
FDA's Biomarker Qualification Program | Videos | Biomarker; Drug Development |
Biosimillars Health Care Provider Materials | Health Care Professionals; Videos; Graphics; Social Media | Biosimilars; Drug Regulatory Process; Drug Development; Disease States; Drug Safety |
FDA Drug Info Rounds | Health Care Professionals; Videos | Drug Safety; MedWatch; IND; Drug Development; Drug Regulatory Process; Prescription Drug Promotion; Disease States; Registration and Listing; Generic Drugs |
GDUFA II Videos and Resources | Videos | Drug Development; Generic Drugs |
Regulatory Science at CDER Videos | Videos | Drug Regulatory Process; Drug Development |
Biosimilars Online Courses, Webinars, and Presentations | Health Care Professionals; Webinars | Biosimliars; Drug Regulatory Process; Drug Development |
CDER Webinars | Health Care Professionals; Webinars | Drug Regulatory Process; Drug Development; Generic Drugs; OTC Drug Regulations; Registration and Listing; Electronic Submissions; Biosimilars; Drug Safety; MedWatch; IND; Disease States; Prescription Drug Promotion; Cancer Drugs |
Division of Drug Information Webinars | Health Care Professionals; Webinars; CE Credits | Drug Regulatory Process; Drug Development; Generic Drugs; OTC Drug Regulations; Biosimilars; Drug Safety; MedWatch; IND; Disease States; Prescription Drug Promotion; Cancer Drugs |
Compounding Quality Center of Excellence On-Demand Training | CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch |
FDA approval of Lynparza (Olaparib) | Health Care Professionals; Patients; Podcasts |
Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Generics-at-a-Glance with Dr. Sarah Ibrahim | Health Care Professionals; Patients; Podcasts | Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
Drug Shortages with CDR Emily Thakur | Health Care Professionals; Patients; Podcasts | COVID-19; Drug Development; Drug Regulatory Process; Drug Safety |
FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska | Health Care Professionals; Patients; Podcasts | Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; OTC Drug Regulations |
FDA Regulation and Quality Considerations for Cannabis and Cannabis-Derived Compounds | Health Care Professionals; Patients; Podcasts | Drug Development; Drug Regulatory Process; Drug Safety; IND |
The Role of Pharmacodynamic Biomarkers in Biosimilar Drug Development | Health Care Professionals; Patients; Podcasts |
Biomarker; Biosimilars; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
Insights About the FDA/EMA Parallel Scientific Advice Program for Complex Generic/Hybrid Drug Products | Health Care Professionals; Patients; Podcasts | Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
CURE ID, A Tool for Clinicians to Report New Uses of Existing Drugs with Heather Stone and Dr. Marco Schito | Case Study; Health Care Professionals; Patients; Podcasts | COVID-19; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch |
CDER Conversation: Improving Medication Adherence and Patient Experience by Researching Patient Perceptions of Generic Drug | Case Study; Health Care Professionals; Patients | Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
Additional Resources
- FDA Continuing Education Programs
- Training and Continuing Education
- FDA Learning Portal for Students, Academia, and Industry
- For questions contact CDER Division of Drug Information
Paragraph Header
Contact Us
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
For Updates on Twitter follow
@FDA_Drug_Info
Your source for the latest drug information.
Know the moment it happens.